Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Daniel Aaron Pollyea

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Pollyea, Daniel

One or more keywords matched the following items that are connected to Pollyea, Daniel

Item Type	Name
Academic Article	Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Academic Article	Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Academic Article	Acute myeloid leukaemia in the elderly: a review.
Concept	Antineoplastic Agents
Academic Article	Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
Academic Article	Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.
Academic Article	Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Academic Article	ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.
Academic Article	Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Academic Article	Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib.
Academic Article	Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Academic Article	PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.
Academic Article	Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Academic Article	Targeting the IDH2 Pathway in Acute Myeloid Leukemia.
Academic Article	Enasidenib for the treatment of acute myeloid leukemia.
Academic Article	Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Concept	Antineoplastic Agents, Immunological
Academic Article	Acute myeloid leukemia drug development in the post-venetoclax era.
Academic Article	How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia.
Academic Article	Hypomethylating agents with venetoclax: have we discovered the holy grail?
Academic Article	Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.
Academic Article	Venetoclax in AML: Where We Are and Where We Are Headed.
Academic Article	Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Academic Article	A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Academic Article	Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Academic Article	Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.

Search Criteria

Antineoplastic Agents